National Heart Institute — Beverly Hills, California

Public research footprint of National Heart Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Atherosclerotic Cardiovascular Disease · Heart Failure · Cardiovascular Disease and Lipoprotein(a) · Atherosclerotic Cardiovascular Disease (ASCVD)

Recently updated registry entries

NCT05952856 — A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With… (Completed)
NCT07614984 — A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a)… (Recruiting)
NCT07448038 — A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Heart Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.